Lundbeck Israel started operating in Israel at the end of 2002. Before that Lundbeck was represented in Israel by a local distributer.
Lundbeck chose to specialize in one main field – the central nervous system (CNS). As the only company in the world specializing in the CNS field, Lundbeck is involved in research, development, production and marketing.
We wish and strive to succeed in this area and develop drugs that are meant to improve the quality of life of people suffering from psychiatric and neurological disorders. The CNS field is wide, and it is expected that in 2015 every third person will, at some point in his life, require drug treatment for treating a medical situation of the CNS.
Today, we have subsidiaries all over the world and we started intensified activities in the U.S., Japan, China and Latin America. In Israel, Lundbeck offices are located in Tel-Aviv and our medical representatives operate across the whole country.
Part of our performance is in creating a permanent dialog with the medical and research community, both in Israel and in the world, aiming to assist in acquiring knowledge, sharing and integrating research and practice tools, in order to promote the medical treatment and integrate it in the most optimal way with drug treatment. Furthermore, we operate for medical education in the community and for increasing the awareness to treatment options and to the patients' different needs by giving tools and knowledge.
Lundbeck will continue operating to bring new products and offer safe, focused and better drug treatment in all treatment areas – depression and anxiety, schizophrenia, bi-polar, addiction and more, as well as in neurological treatment where we will continue with the treatment of Alzheimer's disease, Parkinson and it the future also stroke.